Multiple Endocrine Neoplasia Type 2B
Also known as: Multiple endocrine neoplasia [MEN] type IIB / Multiple endocrine neoplasia type III / Multiple endocrine neoplasia Type IIB / Multiple endocrine adenomatosis Type IIb / Multiple endocrine neoplasia, type 3 (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01101 | Capecitabine | 1 | Withdrawn | 1 |
| DB00853 | Temozolomide | 1 | Withdrawn | 1 |
| DB07232 | Veliparib | 1 | Withdrawn | 1 |
| DB05294 | Vandetanib | 1 / 2 | Completed | 1 |
| DB00398 | Sorafenib | 2 | Completed | 1 |